• Wildcard: BICO, Bioprinting, and Bioconvergence

  • Dec 15 2021
  • Durée: 26 min
  • Podcast

Wildcard: BICO, Bioprinting, and Bioconvergence

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.

    This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before having to test them on animals or humans.

    We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.

    Stocks: (OM:BICO)

    Check out more of our content here:

    Podcasts

    Youtube

    Twitter

    Reach us by Email @ IndustryFocus@fool.com
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de Wildcard: BICO, Bioprinting, and Bioconvergence

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.